U.S. court permits generic version of Teva MS drug a year sooner

[riky]

U.S. court permits generic version of Teva MS drug a year sooner

By Diane Bartz and Ransdell Pierson WASHINGTON/NEW YORK (Reuters) - Teva Pharmaceutical Industries' $4 billion-a-year multiple sclerosis drug Copaxone will lose its patent protection in 2014 rather than 2015 because of a ruling from a U.S. appeals court on Friday, making it potentially prey to cheaper generics next May. The U.S. Court of Appeals for the Federal Circuit issued its decision in a patent fight that pits Teva against two teams developing cheaper generic forms of Copaxone: one with Novartis AG and Momenta Pharmaceuticals Inc and another between Mylan Inc and Natco Pharma Ltd. ...

Source: You are not allowed to view links. Register or Login